- Home
- Pharmaceuticals
- 040-000-249 10-Deacetylbaccatin III, CAS 32981-86-5
040-000-249 10-Deacetylbaccatin III, CAS 32981-86-5
Synonyms | 10-Deacetylbaccatin III, 10-DAB III |
Source | Taxus Chinensis |
Keywords | Intermediate, taxane, paclitaxel, cancer, Canada Yew tree |
Related products | Paclitaxel (Taxol), Taxus Chinensis Extract |
- Description
Description
Description
10-Deacetylbaccatin III Specifications
Product Name | 10-Deacetylbaccatin III |
CAS Registry Number | 32981-86-5 |
Molecular Formula | C29H36O10 |
Molecular Weight | 544.60 |
Purity | 99% HPLC |
Appearance | White powder |
Shelf life | 2years |
Solubility | Soluble in DMSO, methanol, ethanol, acetonitrile; insoluble in water |
10-Deacetylbaccatin III Description
10-deacetylbaccatin III (10-DAB) is extracted from Taxus Chinensis. It is the fifth intermediate in the biosynthetic pathway of paclitaxel. 10-DAB is also an essential intermediate in the biosynthetic of taxane.
10-Deacetylbaccatin III Applications
- Pharmaceutical intermediate
- Pesticide intermediate
Reference
- Barboni L, Giarlo G, Ballini R, Fontana G. 14Beta-hydroxy-10-deacetylbaccatin III as a convenient, alternative substrate for the improved synthesis of methoxylated second-generation taxanes. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5389-91. Epub 2006 Aug 4.
- Georgopoulou K, Smirlis D, Bisti S, Xingi E, Skaltsounis L, Soteriadou K. In vitro activity of 10-deacetylbaccatin III against Leishmania donovani promastigotes and intracellular amastigotes. Planta Med. 2007 Aug;73(10):1081-8. Epub 2007 Aug 9.
- Zhang JF, Gong S, Guo ZG. Effects of different elicitors on 10-deacetylbaccatin III-10-O-acetyltransferase activity and cytochrome P450 monooxygenase content in suspension cultures of Taxus cuspidata cells. Cell Biol Int Rep (2010). 2010;18(1):e00009. doi: 10.1042/CBR20110001. Epub 2011 Apr 8.
- Frapolli R, Marangon E, Zaffaroni M, Colombo T, Falcioni C, Bagnati R, Simone M, D’Incalci M, Manzotti C, Fontana G, Morazzoni P, Zucchetti M. Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral c-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors. Drug Metab Dispos. 2006 Dec;34(12):2028-35.
Submit your review | |
1 2 3 4 5 | |
Submit Cancel |
Create your own review
10-Deacetylbaccatin III
Average rating: 1 reviews
Sep 20, 2019
by Kimberly L. Torres on 10-Deacetylbaccatin III
Quality and Cost saving